|
|
| | 9-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-2,3,4,4a,9,9a-hexahydro-1H-carbazole Basic information |
| Product Name: | 9-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-2,3,4,4a,9,9a-hexahydro-1H-carbazole | | Synonyms: | 9-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-2,3,4,4a,9,9a-hexahydro-1H-carbazole;9-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,2,3,4,4a,9a-hexahydrocarbazole;CP-352664 | | CAS: | 1097883-05-0 | | MF: | C18H18N4 | | MW: | 290.36232 | | EINECS: | | | Product Categories: | | | Mol File: | 1097883-05-0.mol | ![9-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-2,3,4,4a,9,9a-hexahydro-1H-carbazole Structure](CAS/20150408/GIF/1097883-05-0.gif) |
| | 9-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-2,3,4,4a,9,9a-hexahydro-1H-carbazole Chemical Properties |
| | 9-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-2,3,4,4a,9,9a-hexahydro-1H-carbazole Usage And Synthesis |
| Uses | CP-352664 is a JAK inhibitor. CP-352664 has a inhibitoinhibits JAK3 with an EC50 value of 210 nM. CP-352664 is promising for research of organ transplant rejection and autoimmune disorders such as rheumatoid arthritis[1]. | | References | [1] Flanagan ME, et al. Discovery of CP-690,550: a potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection. J Med Chem. 2010 Dec 23;53(24):8468-84. DOI:10.1021/jm1004286 |
| | 9-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-2,3,4,4a,9,9a-hexahydro-1H-carbazole Preparation Products And Raw materials |
|